SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure and negative sentiment as investors express frustration over the stock's significant underperformance compared to the broader market and other major tech peers. The community is actively debating the impact of recent leadership changes, the evolving relationship with OpenAI, and broader geopolitical concerns, with many investors closely watching support levels as they weigh the potential for a long-term turnaround against current technical weakness.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing heightened volatility and intense social media scrutiny following reports that Publicis Groupe has ceased recommending the platform to clients after a third-party audit allegedly uncovered billing discrepancies. While the company has publicly refuted these claims as a mischaracterization of standard privacy-driven contract disputes, investors remain deeply divided, with many debating whether the decline is a temporary negotiation tactic or a structural threat to the company's long-term agency relationships.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with knife is generating significant community buzz as a multichain meme coin, with investors highlighting its deflationary burn mechanism and organic growth. Enthusiasts are actively positioning it as a top contender in the current meme sector, frequently comparing its potential to established assets while celebrating its expansion across multiple blockchain ecosystems.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing high volatility as investors weigh strong 2026 revenue guidance and a significant backlog against concerns regarding earnings misses and contract execution. The community is actively debating the stock's long-term potential in lunar infrastructure versus the risks of share dilution, while keeping a close eye on upcoming NASA Lunar Terrain Vehicle contract announcements.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio shares are experiencing intense volatility and heavy volume as traders react to a warning letter from the FDA regarding the company's promotional materials and marketing claims. While the community is actively debating whether this represents a meaningful regulatory setback or a coordinated short-selling catalyst designed to shake out retail investors, long-term bulls are largely doubling down and pointing to the company's existing global drug approvals and clinical data as evidence that the fundamental outlook remains unchanged.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors grapple with a persistent sell-off that has defied strong earnings reports and analyst upgrades, fueling intense community speculation about potential market manipulation, technical gap-filling, or a strategic move to facilitate a low-cost acquisition by PepsiCo. Shareholders are actively debating the leadership's role in the decline, with many expressing frustration over the stock's disconnect from its underlying growth metrics.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is facing a volatile sell-off as investors react to the Clarity Act, which proposes strict new limitations on the ability to earn passive yield on stablecoin balances. While some traders view the price drop as an overreaction that ignores the stock's long-term utility in the payments sector, others in the community are concerned that restricting interest-bearing products could fundamentally weaken Circle's revenue model.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently trending as shareholders react to a mandatory reverse stock split, sparking intense debate within the community regarding the company's long-term viability and management's leadership. Investors are actively divided between those bracing for further volatility and potential dilution, and a vocal contingent anticipating institutional interest or a future short squeeze.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as retail investors react to the Fundrise Innovation Fund's recent NYSE listing, which provides rare public access to high-profile private AI and tech companies like Anthropic, OpenAI, and SpaceX. While the community is actively debating the sustainability of the current price premium over net asset value and the impact of the six-month lockup on shares, bullish sentiment remains strong due to the fund's portfolio and limited float.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing heightened volatility and selling pressure as investors weigh news of a potential bipartisan Senate bill aiming to ban sports-related contracts on prediction markets like Kalshi and Polymarket. While some market participants see this legislation as a regulatory moat for established sportsbooks, others are increasingly concerned about insider selling, high management turnover, and the stock's persistent inability to sustain gains despite positive sector developments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Voss Capital LP Boosts Stake in Actuate Therapeutics, Inc. $ACTU

Voss Capital LP raised its holdings in shares of Actuate Therapeutics, Inc. (NASDAQ:ACTU - Free Report) by 213.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities...

Actuate Therapeutics (NASDAQ:ACTU) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded shares of Actuate Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...

Actuate Therapeutics (NASDAQ:ACTU) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded Actuate Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Mettler-Toledo Q4 Earnings Top Estimates, Sales Rise Y/Y

MTD beats Q4 estimates as adjusted EPS jumps 8% Y/Y and sales rise to $1.13B, led by solid growth across Laboratory, Industrial and Food Retail.

Actuate Therapeutics, Inc. (NASDAQ:ACTU) Sees Significant Growth in Short Interest

Actuate Therapeutics, Inc. (NASDAQ:ACTU - Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 529,786...

Actuate Therapeutics (NASDAQ:ACTU) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen downgraded Actuate Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Actuate Therapeutics (NASDAQ:ACTU) Trading 2.7% Higher - Here's What Happened

Actuate Therapeutics (NASDAQ:ACTU) Trading 2.7% Higher - Time to Buy...

Actuate Therapeutics, Inc. (ACTU) Upgraded to Buy: What Does It Mean for the Stock?

Actuate Therapeutics, Inc. (ACTU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Voss Capital LP Purchases 143,759 Shares of Actuate Therapeutics, Inc. $ACTU

Voss Capital LP grew its position in Actuate Therapeutics, Inc. (NASDAQ:ACTU - Free Report) by 101.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 286,140...

How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06%

The average of price targets set by Wall Street analysts indicates a potential upside of 214.1% in Actuate Therapeutics, Inc. (ACTU). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.24	--	--	N/A
Q3 '25	-$0.26	--	--	N/A
Q2 '25	-$0.30	-$0.30	--	EXPECTED
Q1 '25	-$0.30	--	--	N/A
Q4 '24	-$0.29	--	--	N/A

ACTU
Actuate Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ACTU News

ACTUActuate Therapeutics Inc.